CoChat

Does surveillance impact on cardiovascular prevention?

Di Chiara, A., Vanuzzo, D. · 2009 · European Heart Journal
Cited by 42

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Many epidemiological projects and clinical trials on determinants of atherosclerotic cardiovascular diseases (CVDs) have been conducted to identify risk factors and demonstrate the reversibility of risk through actions directed at their reduction, both in healthy subjects and in patients with established CVDs. At the international level, the Seven Countries Study identified risk factors common to different cultures, consistent for their importance, predictive power, and frequency among the general population.1 Smoking habit, and a rich diet with consequent high levels of total cholesterol and high blood pressure, were ascertained to be partly responsible for differences in the incidence of stroke and coronary heart disease (CHD) between countries.2,3 The WHO's European Collaborative Trial of the multifactorial prevention of CHD demonstrated the reversibility of risk among European populations, through healthier lifestyles and treatment of high risk subjects.4 To this extent the North Karelia Project represents the best example of community-based primary prevention.5 In all these studies, risk factors were carefully standardized and CVD incident events and deaths validated. The scenario may be different when evaluating whole countries. In fact in most industrialized countries CHD mortality has decreased since 1960, but in others it has increased. Time trends have been described for total cholesterol, smoking habit, blood pressure, and body mass index. However, the comparability of mortality and risk factors data was poor. The MONICA-WHO Project (Monitoring Trends and Determinants in Cardiovascular Disease) was the first multinational large-scale study specifically designed to understand the wide variations in CHD and stroke mortality among different countries, and to assess whether the mortality changes were real, and whether they were related to changes in CHD incidence, case fatality/survival, trends in classical risk factors, or advances in coronary care.6 MONICA monitored 37 populations in 21 countries and collected data on >166 000 coronary events in men and women between the ages of 35 and 64 years. According to MONICA data, in men CHD mortality rates decreased in 25 populations and increased in 11 populations while in women CHD mortality rates decreased in 22 populations and increased in 13 populations. In percentage terms, the decrease in mortality rates in the MONICA data was less than that recorded in official mortality rates based on death certificate data.7 The MONICA Project demonstrated the substantial contribution of both decreased incidence and increased survival, as well as the spontaneous changes in the prevalence of risk factors, to the declining trend of mortality: one-third of the decline in mortality was explained by changes in case fatality rates related to advances in coronary care and two-thirds by declining incidence in coronary events as partly explained by the reduction of classical risk factors.7,8 Endeavours such as the MONICA Project are not sustainable in the long term, because of costs and evolving concepts in the classification of CHD non-fatal events.9 The IMPACT model10 may be an important way to overcome those problems, because it relies on CHD mortality and published data on risk factors and treatments. With this approach, several papers have been published recently,11 including that by Björck et al.12 The authors report that between 1986 and 2002, CHD mortality rates in Sweden decreased by 53% in men and 52% in women, aged 25–84 years. During the same period, all-cause mortality declined by 400/100 000 in men (–27%) and 186/100 000 (–18%) in women. The contribution of CHD to all-cause mortality thus declined from 36.7 and 28.6% in 1986 to 23.4 and 16.8% in 2002 in men and women, respectively. Evidence from the study of Björck et al., 12 from a recent IMPACT-Italy model,13 and from previous studies (Figure 1) consistently suggests that 50–75% of the decrease in cardiac deaths can be attributed to population-wide improvements in the major risk factors, particularly smoking, total cholesterol (dramatically, in the present study a 10.4% level of reduction accounted for a reduction of 39% in total CHD mortality), and blood pressure. The remaining 25–50% of the decreased mortality is generally explained by modern cardiology treatments for known CHD patients, such as thrombolysis, angiotensin-converting enzyme (ACE) inhibitors, statins, and perhaps revascularization procedures (coronary artery bypass surgery and coronary angioplasty). Among treatments, a major role (∼35%) is played by pharmacological treatments, both in the acute phase and for secondary prevention, whereas coronary artery bypass surgery and angioplasty accounted for <1% of deaths prevented or postponed. It is somewhat disappointing to read that primary percutaneous coronary intervention (PCI) prevented or postponed only 40 deaths among 20 955 patients suffering from acute myocardial infarction in Sweden in 200

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehp025

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 42

Metadata

Authors
Di Chiara, A., & Vanuzzo, D.
Venue
European Heart Journal
Published
2009-02-19
Volume
30
Issue
9
Pages
1027-1029
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2150537627
Cited by
42
References
3
FWCI
2.47
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does surveillance impact on cardiovascular prevention? https://app.cochat.ai/papers/10.1093/eurheartj/ehp025
The paper
Di Chiara, A., & Vanuzzo, D. (2009). Does surveillance impact on cardiovascular prevention? European Heart Journal. https://doi.org/10.1093/eurheartj/ehp025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.